Reliability of self-report of cannabis use among patients with schizophrenia

Psychiatry Res. 2022 May:311:114491. doi: 10.1016/j.psychres.2022.114491. Epub 2022 Mar 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cannabinoid Receptor Agonists / therapeutic use
  • Cannabis*
  • Hallucinogens* / therapeutic use
  • Humans
  • Marijuana Abuse* / complications
  • Reproducibility of Results
  • Schizophrenia* / complications
  • Schizophrenia* / drug therapy
  • Self Report

Substances

  • Cannabinoid Receptor Agonists
  • Hallucinogens